Literature DB >> 17080217

Rat models of myocardial infarction. Pathogenetic insights and clinical relevance.

Ravinay Bhindi1, Paul K Witting, Aisling C McMahon, Levon M Khachigian, Harry C Lowe.   

Abstract

Animal models of cardiovascular pathology contribute towards understanding and treatment of a broad range of conditions. Specifically in the context of acute myocardial infarction (AMI), rat models have been commonly used in studies of pathogenesis, investigation and novel therapies, although there has often been difficulty in translating experimental findings to clinical benefit. However, recent years have seen two important changes to our clinical approaches to AMI. First, there is increasing recognition that the pathophysiology of human AMI is a process occurring at many levels, not just within the epicardial coronary artery, but also within the microvasculature and the myocardium. Second, contemporary treatments are shifting away from thrombolytic dissolution of epicardial coronary thrombus to direct mechanical approaches using angioplasty and stents. These changes in our understanding of AMI have implications for the relevance of these animal models. The following discussion therefore reviews and examines the current rat models of AMI, places them in a clinical context, discusses their advantages and limitations, and outlines likely future developments, providing an overview of the place of these important models of AMI.

Entities:  

Mesh:

Year:  2006        PMID: 17080217

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  15 in total

1.  Early markers for myocardial ischemia and sudden cardiac death.

Authors:  Sara Sabatasso; Patrice Mangin; Tony Fracasso; Milena Moretti; Mylène Docquier; Valentin Djonov
Journal:  Int J Legal Med       Date:  2016-07-08       Impact factor: 2.686

2.  The cardioprotective efficacy of TVP1022 in a rat model of ischaemia/reperfusion.

Authors:  Offir Ertracht; Esti Liani; Noa Bachner-Hinenzon; Orit Bar-Am; Luba Frolov; Elena Ovcharenko; Huda Awad; Shany Blum; Yaron Barac; Tamar Amit; Dan Adam; Moussa Youdim; Ofer Binah
Journal:  Br J Pharmacol       Date:  2011-06       Impact factor: 8.739

3.  Multiplex analysis of mass imaging data: Application to the pathology of experimental myocardial infarction.

Authors:  Han Shi; Mary El Kazzi; Yuyang Liu; Antony Gao; Angie L Schroder; Sally Vuong; Pamela A Young; Benjamin S Rayner; Caryn van Vreden; Nicholas J C King; Paul K Witting
Journal:  Acta Physiol (Oxf)       Date:  2022-02-01       Impact factor: 7.523

4.  Automated quantification of myocardial salvage in a rat model of ischemia-reperfusion injury using 3D high-resolution magnetic resonance imaging (MRI).

Authors:  Stuart M Grieve; Jawad Mazhar; Fraser Callaghan; Cindy Y Kok; Sarah Tandy; Ravinay Bhindi; Gemma A Figtree
Journal:  J Am Heart Assoc       Date:  2014-07-23       Impact factor: 5.501

5.  New coronary retroinfusion technique in the Rat infarct model: transjugular cardiac vein catheterization.

Authors:  Zheyong Huang; Yunli Shen; Hongmin Zhu; Jianfeng Xu; Yanan Song; Xinying Hu; Zhang Shuning; Xiangdong Yang; Aijun Sun; Juying Qian; Junbo Ge
Journal:  Exp Anim       Date:  2013

6.  The cardioprotective efficacy of TVP1022 against ischemia/reperfusion injury and cardiac remodeling in rats.

Authors:  Assaf Malka; Offir Ertracht; Noa Bachner-Hinenzon; Irina Reiter; Ofer Binah
Journal:  Pharmacol Res Perspect       Date:  2016-11-22

7.  The impact of empagliflozin on cardiac physiology and fibrosis early after myocardial infarction in non-diabetic rats.

Authors:  Elias Daud; Offir Ertracht; Nadav Bandel; Gassan Moady; Monah Shehadeh; Tali Reuveni; Shaul Atar
Journal:  Cardiovasc Diabetol       Date:  2021-07-02       Impact factor: 9.951

8.  Potential advantages of cell administration on the inflammatory response compared to standard ACE inhibitor treatment in experimental myocardial infarction.

Authors:  Michele M Ciulla; Elisa Montelatici; Stefano Ferrero; Paola Braidotti; Roberta Paliotti; Giuseppe Annoni; Elisa De Camilli; Giuseppe Busca; Luisa Chiappa; Paolo Rebulla; Fabio Magrini; Lorenza Lazzari
Journal:  J Transl Med       Date:  2008-06-12       Impact factor: 5.531

9.  Establishment of a rat model of myocardial infarction with a high survival rate: A suitable model for evaluation of efficacy of stem cell therapy.

Authors:  G Srikanth; P Prakash; N Tripathy; M Dikshit; S Nityanand
Journal:  J Stem Cells Regen Med       Date:  2009-04-08

10.  Hydrosulfide attenuates acute myocardial ischemic injury through the glycogen synthase kinase-3β/β-catenin signaling pathway.

Authors:  Ning Ge; Chao Liu; Guofeng Li; Lijun Xie; Qinzeng Zhang; Liping Li; Na Hao; Jianxin Zhang
Journal:  Int J Mol Med       Date:  2016-03-24       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.